 | • レポートコード：MRC2-11QY00977 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はH1N1ワクチンのグローバル市場について調査・分析したレポートです。種類別（筋肉内ワクチン、鼻腔内ワクチン、皮内ワクチン）市場規模、用途別（インフルエンザ、髄膜炎菌、子宮頸がん、肺炎球菌、肝炎、はしか、おたふく風邪、風疹、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別H1N1ワクチンの競争状況、市場シェア ・世界のH1N1ワクチン市場：種類別市場規模 2015年-2020年（筋肉内ワクチン、鼻腔内ワクチン、皮内ワクチン） ・世界のH1N1ワクチン市場：種類別市場規模予測 2021年-2026年（筋肉内ワクチン、鼻腔内ワクチン、皮内ワクチン） ・世界のH1N1ワクチン市場：用途別市場規模 2015年-2020年（インフルエンザ、髄膜炎菌、子宮頸がん、肺炎球菌、肝炎、はしか、おたふく風邪、風疹、その他） ・世界のH1N1ワクチン市場：用途別市場規模予測 2021年-2026年（インフルエンザ、髄膜炎菌、子宮頸がん、肺炎球菌、肝炎、はしか、おたふく風邪、風疹、その他） ・北米のH1N1ワクチン市場分析：米国、カナダ ・ヨーロッパのH1N1ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのH1N1ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のH1N1ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのH1N1ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Baxter International、Sanofi、GSK、Pfizer、Mitsubishi Tanabe Pharma、Hualan Biological Engineering、Cipla、Merck、Sinovac Biotech ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global H1N1 vaccination market is anticipated to boost in the focus period due to the rising cases of swine flu. Additionally, the rising geriatric population increases the risk of respiratory tract diseases, and immune deficient diseases, thus increasing the risk factor for acquiring H1N1 influenza. Moreover, increased research in the field of vaccine technologies and significant government support are driving this market. However, lack of awareness and absence of experienced medical professionals are restraining the growth of H1N1 vaccines market. Furthermore, high capital requirement and stringent regulations are also hindering the growth of the global H1N1 vaccination market.
Market Analysis and Insights: Global H1N1 Vaccines Market
The global H1N1 Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global H1N1 Vaccines Scope and Market Size
H1N1 Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global H1N1 Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the H1N1 Vaccines market is segmented into
Intramuscular Vaccines
Intranasal Vaccines
Intradermal Vaccines
Segment by Application, the H1N1 Vaccines market is segmented into
Influenza
Meningococcal
Cervical Cancer
Pneumococcal
Hepatitis
Measles
Mumps
Rubella
Others
Regional and Country-level Analysis
The H1N1 Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the H1N1 Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and H1N1 Vaccines Market Share Analysis
H1N1 Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in H1N1 Vaccines business, the date to enter into the H1N1 Vaccines market, H1N1 Vaccines product introduction, recent developments, etc.
The major vendors covered:
Abbott
Baxter International
Sanofi
GSK
Pfizer
Mitsubishi Tanabe Pharma
Hualan Biological Engineering
Cipla
Merck
Sinovac Biotech
1 Study Coverage
1.1 H1N1 Vaccines Product Introduction
1.2 Market Segments
1.3 Key H1N1 Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global H1N1 Vaccines Market Size Growth Rate by Type
1.4.2 Intramuscular Vaccines
1.4.3 Intranasal Vaccines
1.4.4 Intradermal Vaccines
1.5 Market by Application
1.5.1 Global H1N1 Vaccines Market Size Growth Rate by Application
1.5.2 Influenza
1.5.3 Meningococcal
1.5.4 Cervical Cancer
1.5.5 Pneumococcal
1.5.6 Hepatitis
1.5.7 Measles
1.5.8 Mumps
1.5.9 Rubella
1.5.10 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global H1N1 Vaccines Market Size, Estimates and Forecasts
2.1.1 Global H1N1 Vaccines Revenue 2015-2026
2.1.2 Global H1N1 Vaccines Sales 2015-2026
2.2 Global H1N1 Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global H1N1 Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global H1N1 Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global H1N1 Vaccines Competitor Landscape by Players
3.1 H1N1 Vaccines Sales by Manufacturers
3.1.1 H1N1 Vaccines Sales by Manufacturers (2015-2020)
3.1.2 H1N1 Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 H1N1 Vaccines Revenue by Manufacturers
3.2.1 H1N1 Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 H1N1 Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global H1N1 Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by H1N1 Vaccines Revenue in 2019
3.2.5 Global H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 H1N1 Vaccines Price by Manufacturers
3.4 H1N1 Vaccines Manufacturing Base Distribution, Product Types
3.4.1 H1N1 Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers H1N1 Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into H1N1 Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global H1N1 Vaccines Market Size by Type (2015-2020)
4.1.1 Global H1N1 Vaccines Sales by Type (2015-2020)
4.1.2 Global H1N1 Vaccines Revenue by Type (2015-2020)
4.1.3 H1N1 Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global H1N1 Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global H1N1 Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global H1N1 Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 H1N1 Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global H1N1 Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global H1N1 Vaccines Market Size by Application (2015-2020)
5.1.1 Global H1N1 Vaccines Sales by Application (2015-2020)
5.1.2 Global H1N1 Vaccines Revenue by Application (2015-2020)
5.1.3 H1N1 Vaccines Price by Application (2015-2020)
5.2 H1N1 Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global H1N1 Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global H1N1 Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global H1N1 Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America H1N1 Vaccines by Country
6.1.1 North America H1N1 Vaccines Sales by Country
6.1.2 North America H1N1 Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America H1N1 Vaccines Market Facts & Figures by Type
6.3 North America H1N1 Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe H1N1 Vaccines by Country
7.1.1 Europe H1N1 Vaccines Sales by Country
7.1.2 Europe H1N1 Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe H1N1 Vaccines Market Facts & Figures by Type
7.3 Europe H1N1 Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific H1N1 Vaccines by Region
8.1.1 Asia Pacific H1N1 Vaccines Sales by Region
8.1.2 Asia Pacific H1N1 Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific H1N1 Vaccines Market Facts & Figures by Type
8.3 Asia Pacific H1N1 Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America H1N1 Vaccines by Country
9.1.1 Latin America H1N1 Vaccines Sales by Country
9.1.2 Latin America H1N1 Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America H1N1 Vaccines Market Facts & Figures by Type
9.3 Central & South America H1N1 Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa H1N1 Vaccines by Country
10.1.1 Middle East and Africa H1N1 Vaccines Sales by Country
10.1.2 Middle East and Africa H1N1 Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa H1N1 Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa H1N1 Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Description and Business Overview
11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott H1N1 Vaccines Products Offered
11.1.5 Abbott Related Developments
11.2 Baxter International
11.2.1 Baxter International Corporation Information
11.2.2 Baxter International Description and Business Overview
11.2.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Baxter International H1N1 Vaccines Products Offered
11.2.5 Baxter International Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description and Business Overview
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi H1N1 Vaccines Products Offered
11.3.5 Sanofi Related Developments
11.4 GSK
11.4.1 GSK Corporation Information
11.4.2 GSK Description and Business Overview
11.4.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GSK H1N1 Vaccines Products Offered
11.4.5 GSK Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer H1N1 Vaccines Products Offered
11.5.5 Pfizer Related Developments
11.6 Mitsubishi Tanabe Pharma
11.6.1 Mitsubishi Tanabe Pharma Corporation Information
11.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
11.6.3 Mitsubishi Tanabe Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Products Offered
11.6.5 Mitsubishi Tanabe Pharma Related Developments
11.7 Hualan Biological Engineering
11.7.1 Hualan Biological Engineering Corporation Information
11.7.2 Hualan Biological Engineering Description and Business Overview
11.7.3 Hualan Biological Engineering Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hualan Biological Engineering H1N1 Vaccines Products Offered
11.7.5 Hualan Biological Engineering Related Developments
11.8 Cipla
11.8.1 Cipla Corporation Information
11.8.2 Cipla Description and Business Overview
11.8.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Cipla H1N1 Vaccines Products Offered
11.8.5 Cipla Related Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Description and Business Overview
11.9.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Merck H1N1 Vaccines Products Offered
11.9.5 Merck Related Developments
11.10 Sinovac Biotech
11.10.1 Sinovac Biotech Corporation Information
11.10.2 Sinovac Biotech Description and Business Overview
11.10.3 Sinovac Biotech Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sinovac Biotech H1N1 Vaccines Products Offered
11.10.5 Sinovac Biotech Related Developments
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Description and Business Overview
11.1.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott H1N1 Vaccines Products Offered
11.1.5 Abbott Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 H1N1 Vaccines Market Estimates and Projections by Region
12.1.1 Global H1N1 Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global H1N1 Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America H1N1 Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: H1N1 Vaccines Sales Forecast (2021-2026)
12.2.2 North America: H1N1 Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: H1N1 Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe H1N1 Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: H1N1 Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: H1N1 Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: H1N1 Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific H1N1 Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: H1N1 Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: H1N1 Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: H1N1 Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America H1N1 Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: H1N1 Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: H1N1 Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: H1N1 Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa H1N1 Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: H1N1 Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: H1N1 Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: H1N1 Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key H1N1 Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 H1N1 Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. H1N1 Vaccines Market Segments
Table 2. Ranking of Global Top H1N1 Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global H1N1 Vaccines Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Intramuscular Vaccines
Table 5. Major Manufacturers of Intranasal Vaccines
Table 6. Major Manufacturers of Intradermal Vaccines
Table 7. Global H1N1 Vaccines Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global H1N1 Vaccines Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global H1N1 Vaccines Sales by Regions 2015-2020 (K MT)
Table 10. Global H1N1 Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global H1N1 Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global H1N1 Vaccines Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global H1N1 Vaccines Sales Share by Manufacturers (2015-2020)
Table 14. Global H1N1 Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global H1N1 Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H1N1 Vaccines as of 2019)
Table 16. H1N1 Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. H1N1 Vaccines Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers H1N1 Vaccines Price (2015-2020) (USD/MT)
Table 19. H1N1 Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers H1N1 Vaccines Product Type
Table 21. Date of International Manufacturers Enter into H1N1 Vaccines Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global H1N1 Vaccines Sales by Type (2015-2020) (K MT)
Table 24. Global H1N1 Vaccines Sales Share by Type (2015-2020)
Table 25. Global H1N1 Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 26. Global H1N1 Vaccines Revenue Share by Type (2015-2020)
Table 27. H1N1 Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global H1N1 Vaccines Sales by Application (2015-2020) (K MT)
Table 29. Global H1N1 Vaccines Sales Share by Application (2015-2020)
Table 30. North America H1N1 Vaccines Sales by Country (2015-2020) (K MT)
Table 31. North America H1N1 Vaccines Sales Market Share by Country (2015-2020)
Table 32. North America H1N1 Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 33. North America H1N1 Vaccines Revenue Market Share by Country (2015-2020)
Table 34. North America H1N1 Vaccines Sales by Type (2015-2020) (K MT)
Table 35. North America H1N1 Vaccines Sales Market Share by Type (2015-2020)
Table 36. North America H1N1 Vaccines Sales by Application (2015-2020) (K MT)
Table 37. North America H1N1 Vaccines Sales Market Share by Application (2015-2020)
Table 38. Europe H1N1 Vaccines Sales by Country (2015-2020) (K MT)
Table 39. Europe H1N1 Vaccines Sales Market Share by Country (2015-2020)
Table 40. Europe H1N1 Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe H1N1 Vaccines Revenue Market Share by Country (2015-2020)
Table 42. Europe H1N1 Vaccines Sales by Type (2015-2020) (K MT)
Table 43. Europe H1N1 Vaccines Sales Market Share by Type (2015-2020)
Table 44. Europe H1N1 Vaccines Sales by Application (2015-2020) (K MT)
Table 45. Europe H1N1 Vaccines Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific H1N1 Vaccines Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific H1N1 Vaccines Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific H1N1 Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific H1N1 Vaccines Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific H1N1 Vaccines Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific H1N1 Vaccines Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific H1N1 Vaccines Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific H1N1 Vaccines Sales Market Share by Application (2015-2020)
Table 54. Latin America H1N1 Vaccines Sales by Country (2015-2020) (K MT)
Table 55. Latin America H1N1 Vaccines Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa H1N1 Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America H1N1 Vaccines Revenue Market Share by Country (2015-2020)
Table 58. Latin America H1N1 Vaccines Sales by Type (2015-2020) (K MT)
Table 59. Latin America H1N1 Vaccines Sales Market Share by Type (2015-2020)
Table 60. Latin America H1N1 Vaccines Sales by Application (2015-2020) (K MT)
Table 61. Latin America H1N1 Vaccines Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa H1N1 Vaccines Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa H1N1 Vaccines Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa H1N1 Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa H1N1 Vaccines Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa H1N1 Vaccines Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa H1N1 Vaccines Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa H1N1 Vaccines Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa H1N1 Vaccines Sales Market Share by Application (2015-2020)
Table 70. Abbott Corporation Information
Table 71. Abbott Description and Major Businesses
Table 72. Abbott H1N1 Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Abbott Product
Table 74. Abbott Recent Development
Table 75. Baxter International Corporation Information
Table 76. Baxter International Description and Major Businesses
Table 77. Baxter International H1N1 Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Baxter International Product
Table 79. Baxter International Recent Development
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Major Businesses
Table 82. Sanofi H1N1 Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Sanofi Product
Table 84. Sanofi Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Major Businesses
Table 87. GSK H1N1 Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. GSK Product
Table 89. GSK Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Major Businesses
Table 92. Pfizer H1N1 Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Pfizer Product
Table 94. Pfizer Recent Development
Table 95. Mitsubishi Tanabe Pharma Corporation Information
Table 96. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 97. Mitsubishi Tanabe Pharma H1N1 Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Mitsubishi Tanabe Pharma Product
Table 99. Mitsubishi Tanabe Pharma Recent Development
Table 100. Hualan Biological Engineering Corporation Information
Table 101. Hualan Biological Engineering Description and Major Businesses
Table 102. Hualan Biological Engineering H1N1 Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Hualan Biological Engineering Product
Table 104. Hualan Biological Engineering Recent Development
Table 105. Cipla Corporation Information
Table 106. Cipla Description and Major Businesses
Table 107. Cipla H1N1 Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Cipla Product
Table 109. Cipla Recent Development
Table 110. Merck Corporation Information
Table 111. Merck Description and Major Businesses
Table 112. Merck H1N1 Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Merck Product
Table 114. Merck Recent Development
Table 115. Sinovac Biotech Corporation Information
Table 116. Sinovac Biotech Description and Major Businesses
Table 117. Sinovac Biotech H1N1 Vaccines Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Sinovac Biotech Product
Table 119. Sinovac Biotech Recent Development
Table 120. Global H1N1 Vaccines Sales Forecast by Regions (2021-2026) (K MT)
Table 121. Global H1N1 Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global H1N1 Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global H1N1 Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: H1N1 Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 125. North America: H1N1 Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: H1N1 Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 127. Europe: H1N1 Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: H1N1 Vaccines Sales Forecast by Region (2021-2026) (K MT)
Table 129. Asia Pacific: H1N1 Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: H1N1 Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 131. Latin America: H1N1 Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: H1N1 Vaccines Sales Forecast by Country (2021-2026) (K MT)
Table 133. Middle East and Africa: H1N1 Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key H1N1 Vaccines Players
Table 138. H1N1 Vaccines Customers List
Table 139. H1N1 Vaccines Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. H1N1 Vaccines Product Picture
Figure 2. Global H1N1 Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Intramuscular Vaccines Product Picture
Figure 4. Intranasal Vaccines Product Picture
Figure 5. Intradermal Vaccines Product Picture
Figure 6. Global H1N1 Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Influenza
Figure 8. Meningococcal
Figure 9. Cervical Cancer
Figure 10. Pneumococcal
Figure 11. Hepatitis
Figure 12. Measles
Figure 13. Mumps
Figure 14. Rubella
Figure 15. Others
Figure 16. H1N1 Vaccines Report Years Considered
Figure 17. Global H1N1 Vaccines Market Size 2015-2026 (US$ Million)
Figure 18. Global H1N1 Vaccines Sales 2015-2026 (K MT)
Figure 19. Global H1N1 Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 20. Global H1N1 Vaccines Sales Market Share by Region (2015-2020)
Figure 21. Global H1N1 Vaccines Sales Market Share by Region in 2019
Figure 22. Global H1N1 Vaccines Revenue Market Share by Region (2015-2020)
Figure 23. Global H1N1 Vaccines Revenue Market Share by Region in 2019
Figure 24. Global H1N1 Vaccines Sales Share by Manufacturer in 2019
Figure 25. The Top 10 and 5 Players Market Share by H1N1 Vaccines Revenue in 2019
Figure 26. H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global H1N1 Vaccines Sales Market Share by Type (2015-2020)
Figure 28. Global H1N1 Vaccines Sales Market Share by Type in 2019
Figure 29. Global H1N1 Vaccines Revenue Market Share by Type (2015-2020)
Figure 30. Global H1N1 Vaccines Revenue Market Share by Type in 2019
Figure 31. Global H1N1 Vaccines Market Share by Price Range (2015-2020)
Figure 32. Global H1N1 Vaccines Sales Market Share by Application (2015-2020)
Figure 33. Global H1N1 Vaccines Sales Market Share by Application in 2019
Figure 34. Global H1N1 Vaccines Revenue Market Share by Application (2015-2020)
Figure 35. Global H1N1 Vaccines Revenue Market Share by Application in 2019
Figure 36. North America H1N1 Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 37. North America H1N1 Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America H1N1 Vaccines Sales Market Share by Country in 2019
Figure 39. North America H1N1 Vaccines Revenue Market Share by Country in 2019
Figure 40. U.S. H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 41. U.S. H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 43. Canada H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. North America H1N1 Vaccines Market Share by Type in 2019
Figure 45. North America H1N1 Vaccines Market Share by Application in 2019
Figure 46. Europe H1N1 Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 47. Europe H1N1 Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 48. Europe H1N1 Vaccines Sales Market Share by Country in 2019
Figure 49. Europe H1N1 Vaccines Revenue Market Share by Country in 2019
Figure 50. Germany H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 51. Germany H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. France H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 53. France H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. U.K. H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 55. U.K. H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Italy H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 57. Italy H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Russia H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 59. Russia H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Europe H1N1 Vaccines Market Share by Type in 2019
Figure 61. Europe H1N1 Vaccines Market Share by Application in 2019
Figure 62. Asia Pacific H1N1 Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 63. Asia Pacific H1N1 Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 64. Asia Pacific H1N1 Vaccines Sales Market Share by Region in 2019
Figure 65. Asia Pacific H1N1 Vaccines Revenue Market Share by Region in 2019
Figure 66. China H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 67. China H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Japan H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 69. Japan H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. South Korea H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 71. South Korea H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. India H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 73. India H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Australia H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 75. Australia H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Taiwan H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 77. Taiwan H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Indonesia H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 79. Indonesia H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Thailand H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 81. Thailand H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Malaysia H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 83. Malaysia H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Philippines H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 85. Philippines H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Vietnam H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 87. Vietnam H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Asia Pacific H1N1 Vaccines Market Share by Type in 2019
Figure 89. Asia Pacific H1N1 Vaccines Market Share by Application in 2019
Figure 90. Latin America H1N1 Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 91. Latin America H1N1 Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America H1N1 Vaccines Sales Market Share by Country in 2019
Figure 93. Latin America H1N1 Vaccines Revenue Market Share by Country in 2019
Figure 94. Mexico H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 95. Mexico H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 97. Brazil H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 99. Argentina H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Latin America H1N1 Vaccines Market Share by Type in 2019
Figure 101. Latin America H1N1 Vaccines Market Share by Application in 2019
Figure 102. Middle East and Africa H1N1 Vaccines Sales Growth Rate 2015-2020 (K MT)
Figure 103. Middle East and Africa H1N1 Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 104. Middle East and Africa H1N1 Vaccines Sales Market Share by Country in 2019
Figure 105. Middle East and Africa H1N1 Vaccines Revenue Market Share by Country in 2019
Figure 106. Turkey H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 107. Turkey H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Saudi Arabia H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 109. Saudi Arabia H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. U.A.E H1N1 Vaccines Sales Growth Rate (2015-2020) (K MT)
Figure 111. U.A.E H1N1 Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. Middle East and Africa H1N1 Vaccines Market Share by Type in 2019
Figure 113. Middle East and Africa H1N1 Vaccines Market Share by Application in 2019
Figure 114. North America H1N1 Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. North America H1N1 Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe H1N1 Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Europe H1N1 Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific H1N1 Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Asia Pacific H1N1 Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America H1N1 Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Latin America H1N1 Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa H1N1 Vaccines Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Middle East and Africa H1N1 Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…- 髄膜炎菌ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Meningococcal Vaccines Market The global Meningococcal Vaccines market size is projected to reach US$ 250.5 million by 2026, from US$ 239 million in 2020, at a CAGR of 4.4%% during 2021-2026. Global Meningococcal Vaccines Scope and Market Size Meningococcal Vacci…
- がんワクチン薬剤用パイプラインの世界市場（～2026年） Cancer vaccines offer an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. Germany, the U.S. and Japan represent the largest markets for cancer vaccine manufacturers. Market Analysis and Insights: Global Cancer Vaccines Drug Pipeline Mark…
- mRNA癌ワクチン・治療薬の世界市場（～2026年） mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically wh…
- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…